Page last updated: 2024-10-16

quinacrine and Experimental Hepatoma

quinacrine has been researched along with Experimental Hepatoma in 2 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Furukawa, F1
Nishikawa, A1
Imazawa, T2
Kasahara, K1
Takahashi, M1
Imaida, K1
Yoshida, J1
Uneyama, C1
Ogasawara, H1
Hayashi, Y1

Other Studies

2 other studies available for quinacrine and Experimental Hepatoma

ArticleYear
Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters.
    Japanese journal of cancer research : Gann, 1998, Volume: 89, Issue:2

    Topics: Animals; Antineoplastic Agents; Body Weight; Carcinogens; Cricetinae; Drug Synergism; Female; Kidney

1998
Dose-dependent enhancing effects of quinacrine on induction of preneoplastic glutathione S-transferase placental form positive liver cell foci in male F344 rats.
    Carcinogenesis, 1991, Volume: 12, Issue:10

    Topics: Animals; Diethylnitrosamine; Dose-Response Relationship, Drug; Drug Synergism; Eating; Enzyme Induct

1991